Matthew Dellatorre

Stock Analyst at Goldman Sachs

(4.69)
# 771
Out of 5,040 analysts
14
Total ratings
100%
Success rate
60.9%
Average return

Stocks Rated by Matthew Dellatorre

Amneal Pharmaceuticals
Aug 10, 2026
Reiterated: Buy
Price Target: $21
Current: $19.65
Upside: +6.87%
Viatris
Oct 22, 2025
Reiterated: Hold
Price Target: $10 → $12
Current: $17.44
Upside: -31.19%